A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics.
Ganesh, Vannakambadi K
A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. [electronic resource] - PLoS pathogens Nov 2008 - e1000226 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1553-7374
10.1371/journal.ppat.1000226 doi
Binding Sites
Coagulase--metabolism
Crystallography, X-Ray
Drug Design
Fibrinogen--metabolism
Models, Molecular
Peptides--chemical synthesis
Protein Binding--drug effects
Staphylococcal Infections--drug therapy
Staphylococcus aureus
A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. [electronic resource] - PLoS pathogens Nov 2008 - e1000226 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1553-7374
10.1371/journal.ppat.1000226 doi
Binding Sites
Coagulase--metabolism
Crystallography, X-Ray
Drug Design
Fibrinogen--metabolism
Models, Molecular
Peptides--chemical synthesis
Protein Binding--drug effects
Staphylococcal Infections--drug therapy
Staphylococcus aureus